PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM.

Blair, Cheríe S; Beymer, Matthew R; Kofron, Ryan M; Bolan, Robert K; Jordan, Wilbert C; Haubrich, Richard H; Wohl, Amy R; Landovitz, Raphael J

Blair, Cheríe S; Beymer, Matthew R; Kofron, Ryan M; Bolan, Robert K; Jordan, Wilbert C; Haubrich, Richard H; Wohl, Amy R; Landovitz, Raphael J.

Afiliação

Blair CS; Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Beymer MR; Department of Community Health Sciences, Fielding School of Public Health at UCLA, Los Angeles, California, USA.
Kofron RM; UCLA Center for Clinical AIDS Research & Education, Los Angeles, California, USA.
Bolan RK; Department of Health and Mental Health Services, Los Angeles LGBT Center, Los Angeles, California, USA.
Jordan WC; OASIS Clinic, Charles R. Drew University of Medicine and Science, Los Angeles, California, USA.
Haubrich RH; Gilead Sciences, Inc., Foster City, California, USA.
Wohl AR; Department of Epidemiology, Fielding School of Public Health at UCLA, Los Angeles, California, USA.
Landovitz RJ; Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Open Forum Infect Dis ; 7(8): ofaa329, 2020 Aug.

Article em En | MEDLINE | ID: mdl-32851110

Palavras-chave

MSM; PrEP adherence; pre-exposure prophylaxis; syphilis; white coat dosing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google